The Obama administration and the new Congress:
Good medicine for the pharma, biotech, and medtech industries?
Hosted by the Ernst & Young Pharmaceutical Center
Ernst & Young is pleased to invite you to join a special guest panel of healthcare industry leaders on February 20 at 11:00 EDT including:
Billy Tauzin, President and CEO of PhRMA
Jim Greenwood, President and CEO of the Biotechnology Industry Organization
Brett Loper, Executive Vice President, Government Affairs from AdvaMed
Special guest:
Mark B. Hassenplug, Global Pharmaceutical Markets Leader, Ernst & Young LLP
Moderators:
Anne Phelps, Prinicpal, Washington Council Ernst & Young LLP
Carolyn Buck Luce, Global Pharmaceutical Sector Leader, Ernst & Young LLP
This unique panel will foster a dynamic discussion
of how the Obama administration and the new Democratic congressional majorities will likely affect the legislative, regulatory and market environment for the life sciences industry. Find out how upcoming healthcare reform proposals will likely affect the pharmaceutical, biotechnology and medical device industries. Hear from key industry leaders as they debate whether these new policies will present new opportunities or risks for the pharma, biotech and medtech sectors.
More...
As Washington changes directions, learn more about who the new players are, which campaign promises are rising to the top of the health reform agenda, and the new business imperatives that are shaping the healthcare market. The webcast will feature topics such as:
Key implications of health system reform on pharma, biotech, and medtech companies
The impact of a new leadership team on HHS, CMS, FDA and other key agencies
The future of pricing
The road to innovation and the challenges of the approval process
What globalization means for these sectors
Critical concerns of the pharma, biotech, and medical device sectors and how they are responding to the challenging economic times.
This webcast is a continuation of our series focused on the impact of the Obama administration on the health sectors and what it will take to survive in a constantly changing and uncertain global marketplace.